Sphere gets CE Mark for second-gen Proxima blood analyzer

12/19/2011 | Reuters

European regulators have granted Sphere Medical CE Mark approval for its Proxima Generation 2 device as an in vitro diagnostic tool. The approval comes after it was reported last month that the device proved to be as effective as point-of-care and laboratory blood gas analyzers in tracking arterial blood in a clinical environment.

View Full Article in:

Reuters

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR